CD274 and neoplasm: Although some studies have shown that tumor PD-L1 expression correlates with the anti-tumor response upon PD-L1 checkpoint blockade in different cancer types [20, 21], other studies showed that PD-L1-negative tumors can respond as well [22, 23].